Based on the mechanism of infection, it is not surprising that patients with comorbidities, such as heart disease, pulmonary disease, and diabetes, are at increased risk due to potential baseline changes in ACE2 expression, changes in RAS system activation, and preexisting pulmonary or cardiac injury with fibrosis, inflammation, or both. Here, ACE2 is linked to diabetes mellitus.